Ticker
PACBCompany Name
PACIFIC BIOSCIENCES OF CALIFORNIA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 55.1M | 0.92 | $ 59.75M |
3/31/2025 | $ 59.2M | 0.89 | $ 66.6M |
12/31/2024 | $ 56.06M | 0.85 | $ 66.3M |
9/30/2024 | $ 78.67M | 1.31 | $ 60M |
6/30/2024 | $ 99.87M | 1.27 | $ 78.39M |
3/31/2024 | $ 76.95M | 1.05 | $ 72.95M |
12/31/2023 | $ 180.21M | 1.9 | $ 95.03M |
9/30/2023 | $ 385.95M | 2.1 | $ 183.96M |
6/30/2023 | $ 209.59M | 0.77 | $ 271.41M |
3/31/2023 | $ 354.13M | 1.33 | $ 265.67M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for PACIFIC BIOSCIENCES OF CALIFORNIA INC is calculated as follows: CashnEq [ $ 69.03M ] / LiabilitesC [ $ 130.27M ]
(=) Cash Ratio [ 0.53 ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |